Lucid Diagnostics Inc. (LUCD) vs Quantum-Si Incorporated (QSI)

Lucid Diagnostics Inc. and Quantum-Si Incorporated are both Medical Devices companies. Lucid Diagnostics Inc. and Quantum-Si Incorporated are of similar size ($172.9M and $170.3M). Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against −53.0%. Lucid Diagnostics Inc. has the higher net margin (−1,193.9% vs −6,138.3%) and the lower return on invested capital (−3,096.5% vs −100.9%). Across the 17 metrics below, Lucid Diagnostics Inc. leads on 10 and Quantum-Si Incorporated on 7.

Valuation

Metric LUCD QSI Medical Devices median
P/E n/m n/m 22.18
P/S 27.91 112.63 2.70
P/B 13.91 1.00 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 26.10 43.01 2.38
Earnings yield (56.63%) (55.42%) (8.22%)
Free cash flow yield (31.04%) (51.83%) (7.80%)

Profitability

Metric LUCD QSI Medical Devices median
Gross margin (21.69%) 35.02% 56.01%
Operating margin (930.84%) (6,887.79%) (15.03%)
Net margin (1,193.87%) (6,138.26%) (20.40%)
Free cash flow margin (866.56%) (5,837.26%) (7.24%)
Return on equity 364.89% (49.11%) (15.32%)
Return on assets (167.51%) (43.98%) (19.72%)
Return on invested capital (3,096.53%) (100.92%) (10.33%)

Growth

Metric LUCD QSI Medical Devices median
Revenue growth (TTM) 24.89% (52.96%) 8.80%
EPS growth (last fiscal year) 34.29% 28.17% —
Revenue growth, 5-year CAGR — — 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LUCD QSI Medical Devices median
Debt to equity 2.15 0.00 0.07
Current ratio 1.33 9.97 2.50
Net debt to EBITDA 0.22 1.36 0.49

Dividend

Metric LUCD QSI Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric LUCD QSI Medical Devices median
Market cap 170.32m 172.91m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack